Introduction
Embryonic stem cells (ESCs) 1 properties differ from mouse cells (1) (2) (3) . These findings are not unexpected given the differences in early embryonic development between mice and humans (4).
One of the foremost questions in the study of hESCs is the identification of factors required for maintenance of the undifferentiated state. hESCs, unlike mESCs (reviewed in 3), cannot be maintained undifferentiated with leukemia inhibitory factor (LIF, 1,2). However, both human and mouse ESCs stay undifferentiated on feeder layers of mouse embryo fibroblasts (MEFs) or in the presence of MEF-conditioned medium Besser, D.
Regulation of Nodal and Lefties by Smad2/3 in hESCs -8-All tissue-culture reagents were purchased from Invitrogen and used in the recommended concentration unless noted otherwise.
Plasmid and Probes
The leftyA-luc construct was generated by PCR from Bacterial Artificial Chromosome #CITBI-E1-2519G10 (Research Genetics). The lefty-A promoter region (+42bp to -4805bp in regard to the transcription start site) was amplified using a primer pair from Integrated DNA Technologies: forward primer: 5'-ttccctgttcttcaaacaccgtcc-3', reverse primer: 5'tcctctagggaggttgaaggagg3'. The amplified PCR fragment was purified with PCR purification kit (Qiagen) and sub-cloned into pGL2Basic (Promega). pRL-null (renilla) luciferase (Promega) was used as a control for transfection efficiency. Cells were co-transfected with components of the TGF<beta> signaling pathway: constitutive active ALK3 and ALK4 (kindly provided by R. Harland, University of California, Berkeley) and Smad7 in pcDNA3, (kindly provided by P. Ten Dijke, Ludwig Institute, Amsterdam, Netherlands, (20) .
RT-PCR Assays
Total RNA was isolated from BGN2 stem cells using Trizol (Invitrogen) and reverse transcribed using MMLV reverse transcriptase (Invitrogen). PCR amplification was performed on a GeneAmp PCR system 9600 (Perkin Elmer) using Taq DNA polymerase (Promega). The PCR reaction for all primer pairs consisted of 25 cycles, apart from <beta>-actin (21 cycles) and lck (28 cycles 
Results

Decrease of nodal, lefty-A and lefty-B expression is the earliest indication of differentiation in hESCs
A previous report has identified 918 genes in H1 hESCs as the signature of the undifferentiated pluripotent state (7). 24% of this set, 204 genes, was also present in mESCs analyzed by similar means (6) . In order to identify genes and/or signaling pathways that are involved in maintaining the undifferentiated state within this pool, 64
genes were selected based on their potential involvement in signal transduction and/or transcriptional regulation. The expression of these genes was assessed by comparative RT-PCR in H1 cells in a time-course after withdrawal of MEF-conditioned medium (CM) (see Supplemental Data). The time-dependent regulation of six of the 64 genes is shown in Figure 1A . Among the different genes tested in hESCs, nodal, lefty-A and lefty-B showed the earliest down-regulation after withdrawal of CM (Supplemental Data and 
Expression Status of Components of the TGF<beta> Signaling Pathway
A list of TGF<beta> pathway components present in the H1 line is shown in Table 1 . The values were determined by global gene expression analysis (7) 
Activation of Smad2/3 selectively regulates the lefty-A promoter
To test whether this promoter construct displayed the same regulation as the endogenous gene, the activation and inhibition of the Smad2/3 pathway in cells cultured in CM and non-CM was performed. Smad2/3 activation was induced by two independent methods, either by the addition of Activin A or by coexpression of the constitutively activated (ca) type I receptor ca-ALK4. Activation of Smad1/5/8 by coexpression of ca-ALK3 was used as a negative control. (Figure 2A ) and increased phosphorylation of Smad2/3 ( Figure 3B ).
To test whether the leftyA-luc construct is regulated in a similar way, its behavior was examined in cells treated with BIO with or without SB-431542 ( Figure 5A ). As expected, the induction of the lefty-A promoter by BIO was suppressed when the drug SB-431542 was co-presented with BIO in BGN2 cells in a similar manner as described for the induction in CM and Activin A ( Figure 5A ), suggesting that activation of the lefty-A promoter as well as the regulation of endogenous nodal, lefty-A and lefty-B and the activation of Smad2/3 in BIO-treated cells requires active signaling through ALK4/5/7.
Discussion
The identification of factors and signaling pathways involved in differentiation of ESCs is of importance for the field of stem cell research and subject of intense investigation.
We show here that the genes for the ligand Nodal and its inhibitors Lefty-A and Lefty-B constitute a group of genes that respond immediately after differentiation is induced by 
TGF<beta> signaling components in human embryonic stem cells
The data presented here demonstrate that nodal, lefty-A and lefty-B are the earliest genes detected whose expression decreases upon differentiation of hESCs and that their regulation is directly dependent on Smad2/3 activation. Interestingly, similar findings have been described in the embryonic node in the mouse (reviewed in 17, 22) , suggesting that the regulation of these genes by Activin/Nodal signaling is a common mechanism during different stages of early development. In the case of the embryonic node, the relevant ligand activating Smad2/3 appears to be Nodal. This might suggest that Nodal -19-itself is also involved in regulating Smad2/3 in the inner cell mass, i.e. the stem cell compartment, in vivo and raises the question whether the regulation of Smad2/3 also occurs in mouse embryonic stem cells (mESCs). Microarray analysis using mESCs grown on feeder cells, showed that mouse nodal, lefty1 and 2 were strongly downregulated upon differentiation (6) . However, when mESCs were grown in the presence of LIF no regulation of lefty1 or Smad2/3 was observed (data not shown). It appears possible that different culture conditions between hESCs (in CM) and mESCs (in LIF) affect the activation of Smad2/3 and regulation of the lefty genes in ESCs. These differences need to be further investigated.
The inhibition of BMP signaling in hESCs seems to be dependent on multiple factors secreted by the mouse embryo fibroblasts (MEFs) into the conditioned medium 
Synergism between the Wnt pathway and Smad2/3 activation in embryonic systems
Activation of Wnt signaling has been implicated in the establishment of stemness in different adult stem cells, e.g. in skin (24) , hematopoetic (25) and embryonic stem cells (1) . Our data suggest that a crosstalk between inhibition of GSK3 by BIO, which has been implicated in Wnt-signaling (1, 19) and Activin/Nodal signaling occurs in the regulation of nodal, lefty-A and lefty-B expression in undifferentiated stem cells. The interaction between these two pathways has been documented in early embryonic
development (reviewed in 10). For instance, ectodermal explants of UV irradiated
Xenopus embryos differentiate to dorsal mesoderm when treated with a combination of Wnt8 and Activin, but not when exposed to either factor alone (26). Activation of Wnt signaling in Xenopus embryos by lithium chloride ultimately leads to increased phosphorylation of Smad2/3 (27) . The mechanism of Wnt/TGF<beta> cooperation may also be direct, since the downstream effector molecules of these pathways, Lef1 and Smad2/3 have been reported to form complexes and act synergistically to activate the Xtwn gene in Xenopus (28) .
Results from studies of targeted deletions in mouse provide further evidence of extensive crosstalk between Wnt signaling and Smad2/3 activation. Primitive streak formation is absent or impaired in Wnt3 -/-mice (29) , and a similar phenotype is also observed in mice deficient for Nodal (14) , ALK4 (30), Smad2 (31-33), FoxH1 (Fast1) (34) and Smad4 (35, 36) . These common phenotypes are indicative of the functional relevance of these molecules and their crosstalk in early mammalian development might be reflected in the regulation of these pathways in hESCs shown here.
Conclusions
Here, it is shown that activation of Smad2/3 is necessary for the expression of nodal, lefty-A and lefty-B. A model ( Figure 6 ) is proposed in which Smad2/3 is directly regulated by ligands in the MEF-CM and expression of Nodal protein may establish a positive forward loop. In addition, inhibition of GSK3 by BIO, which has been implicated in Wnt-signaling, regulates these genes depending on ALK4,5,7. Inhibition of GSK3 establishes crosstalk to the Activin/Nodal signaling pathway via a yet unknown factor/s to induce increased levels of expression of nodal, lefty-A and lefty-B.
Interestingly, in the undifferentiated state of hESCs, there are two mechanisms that account for the inhibition of ALK2/3/6 signaling, one is dependent on the Smad2/3 activation and appears to involve factors from the hESCs, possibly Cerberus (Table 1) ,
the other one appears to involve factors secreted by the MEFs, such as Gremlin. transfection. Luciferase activity was determined and displayed as described in Figure 4B .
(B) BGN2 cells were transfected with 500 ng lefty-A-luc and 50 ng pRL-null and cotransfected with 500ng pDH105 (CM and non-CM) or expression vectors for ca-ALK3, ca-ALK4, and the inhibitory Smad7. Luciferase activity was determined 36hr after transfection and displayed as described in Figure 4B . Table 1 shows the expression levels of several TGF<beta> pathway components as observed in a global expression profile using microarrays on the Affymetrix U133A Chip * There were relevant genes, e.g. nodal, that are not represented on the U133A chip.
However, nodal was found to be expressed in hESCs in other studies (8, 9) . 
